SAN DIEGO and TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.09 | -9.27835051546 | 0.97 | 0.97 | 0.86 | 5042 | 0.88603104 | CS |
4 | -0.16 | -15.3846153846 | 1.04 | 1.12 | 0.86 | 7429 | 1.00320029 | CS |
12 | -0.82 | -48.2352941176 | 1.7 | 1.73 | 0.86 | 6845 | 1.26959461 | CS |
26 | -1.82 | -67.4074074074 | 2.7 | 2.92 | 0.86 | 8132 | 1.76079823 | CS |
52 | -4.86 | -84.668989547 | 5.74 | 6.9 | 0.86 | 6141 | 2.40600028 | CS |
156 | -53.27 | -98.3748845799 | 54.15 | 58.65 | 0.86 | 22060 | 24.69524596 | CS |
260 | -58.97 | -98.529657477 | 59.85 | 189.3 | 0.86 | 36384 | 80.28247252 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.